Data Critical/Elixis merger extends wireless capabilitiesPursuing its goal of creating a wireless, Web-based clinical information system, Data Critical has agreed to buy Elixis, a privately held company that offers Web-based applications to access
Data Critical/Elixis merger extends wireless capabilities
Pursuing its goal of creating a wireless, Web-based clinical information system, Data Critical has agreed to buy Elixis, a privately held company that offers Web-based applications to access patient information and to automate repetitive tasks like coding and letter and prescription writing. Terms of the deal have yet to be disclosed.
This latest purchase closely follows Data Criticals acquisition of Physix, a provider of mobile handheld workflow applications, for approximately $4.9 million in December 1999. Elixis will become part of a Data Critical subsidiary and will continue its existing distribution partnerships with Baxter Healthcare and Boston Scientific and its strategic alliances with drugstore.com, CVS.com, Physicians Online, MD Consult, and Healthstream.
© 2000 Miller Freeman, Inc., a United News & Media company.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.